ArticleNeoplasia (New York, N.Y.)2024

Spatial profiling of METex14-altered NSCLC under tepotinib treatment: Shifting the immunosuppressive landscape.

Manon A Simard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.